ANTISENSE MODULATION OF UROKINASE PLASMINOGEN ACTIVATOR EXPRESSION

Details for Australian Patent Application No. 2002255784 (hide)

Owner ISIS PHARMACEUTICALS, INC.

Inventors FREIER, Susan, M.; WATT, Andrew, T.; BAKER, Brenda, F.

Pub. Number AU-A-2002255784

PCT Pub. Number WO2002/079515

Priority 09/821,972 30.03.01 US

Filing date 18 March 2002

Wipo publication date 15 October 2002

International Classifications

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C12N 005/00 Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 015/85 Mutation or genetic engineering - for animal cells

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07H 021/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

3 April 2003 Application Open to Public Inspection

  Published as AU-A-2002255784

19 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002255785-Gaseous blend of CO2 and OX and it's use for biological burden reduction

2002255783-COMPOSITIONS AND METHODS FOR INHIBITING THE PROLIFERATION AND INVASIVENESS OF MALIGNANT CELLS COMPRISING EDOMAIN PEPTIDES OF IGF-I